Transgenic Group (TSE:2342) Beta: -0.3631 (As of Jun. 29, 2026)


TSE:2342 Transgenic Group Inc TSE:2342
59 GF Score
Price 円207.00
GF Value 円257.18
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Transgenic Group Beta?

Transgenic Group TSE:2342 -0.96% 59 Beta is -0.3631 as of Jun. 29, 2026. GuruFocus rates TSE:2342 with a GF Score™ of 59/100 and a GF Value™ of 円257.18 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-29), Transgenic Group's Beta is -0.3631.


Transgenic Group  (TSE:2342) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Transgenic Group Beta Related Terms


Transgenic Group Beta Historical Data

* Premium members only.

The historical data trend for Transgenic Group's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Transgenic Group Beta Chart

Transgenic Group Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.13 1.14 0.66 0.26 -0.45

Transgenic Group Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.66 0.56 0.26 0.11 -0.45

TSE:2342 vs VRTX, REGN, ALNY: Beta Comparison

For the Biotechnology subindustry, Transgenic Group's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Transgenic Group Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Transgenic Group's Beta distribution charts can be found below:

* The bar in red indicates where Transgenic Group's Beta falls into.


TSE:2342
59GF Score
Transgenic Group Inc TSE:2342
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Transgenic Group Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.3631 mean?
Transgenic Group (TSE:2342) has a Beta of -0.3631 as of Jun. 29, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Transgenic Group and its competitors.
Is Transgenic Group's Beta too high?
Transgenic Group's current Beta is -0.3631. Overall, Transgenic Group has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Transgenic Group's Beta compare to VRTX and REGN?
Transgenic Group's Beta of -0.3631 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Transgenic Group and its competitors. Transgenic Group's current Beta is -0.3631. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Transgenic Group stock overvalued right now?
Based on GuruFocus' analysis, Transgenic Group (TSE:2342) is currently considered Modestly Undervalued. The stock's GF Value™ is 円257.18, compared to a current price of 円207.00 — trading 19.5% below its estimated fair value. The current Beta is -0.3631. Transgenic Group's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Transgenic Group (TSE:2342), the current Beta is -0.3631 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Transgenic Group (TSE:2342) Overvalued in 2026?

Based on GuruFocus' analysis, Transgenic Group stock appears to be undervalued. The current stock price of 円207.00 is trading 19.5% below its estimated GF Value™ of 円257.18. GuruFocus considers Transgenic Group to be Modestly Undervalued.

Key valuation signals for TSE:2342:

  • Beta: -0.3631
  • GF Value™: 円257.18 vs. price of 円207.00 (19.5% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the TSE:2342 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Transgenic Group Business Description

Address 2-3-36 Tenjin, Chuo-ku, Fukuoka Prefecture, Fukuoka, JPN
Transgenic Group Inc formerly Trans Genic Inc is engaged in offering assistance of non-clinical experiments using large animals and general rearing management work, and non-clinical trial service using large animals. The company has two segments: Drug discovery support business, and Investment and consulting business.
59GF Score

Get the complete analysis for TSE:2342

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円207.00
Price
円257.18
GF Value